A patient who signs a form in reception minutes before an injectable procedure has not necessarily given meaningful consent. To improve consent in aesthetic clinics, clinicians must treat it as a continuing clinical process: one that tests understanding, protects autonomy and supports decisions that remain appropriate when expectations, anatomy and risk are properly considered.
In aesthetic medicine, this standard matters particularly. Procedures may be elective, but their consequences can be physical, psychological, financial and long-lasting. A technically successful treatment can still represent poor care if the patient did not understand the likely outcome, the limitations, the alternatives or the possibility of complications. Consent is therefore not administrative protection. It is an expression of professional judgement and respect for the patient.
Why consent requires greater care in aesthetic medicine
The aesthetic consultation can carry pressures that are less visible in other clinical settings. Patients may arrive influenced by social media imagery, a forthcoming event, a relationship change or a desire to correct a feature they see as disproportionate. Some have researched extensively; others have absorbed persuasive claims without understanding the biological realities of treatment.
The clinician's role is not to validate every requested intervention. It is to determine whether treatment is medically and ethically suitable, whether expectations are realistic, and whether the patient has sufficient time and information to decide freely. This is especially relevant where treatments are repeated, where facial proportions may be altered over time, or where a patient requests escalating volumes or increasingly frequent procedures.
A strong consent process also distinguishes a medically led clinic from a beauty-led service. It places tissue health, safety and proportionality before a transaction. That principle should be evident from the first enquiry through to aftercare and review.
Improve consent in aesthetic clinics through the consultation
Meaningful consent begins well before the consent form appears. The initial consultation should create enough space to understand why the patient is seeking treatment, what they believe it can achieve and what may be driving their decision. Open questions are more revealing than asking whether they would like a particular product or procedure.
Ask the patient what concerns them, what outcome they hope to see and how they would judge the treatment to have been worthwhile. Their answers may reveal an appropriate and achievable aim, but they may also identify a misunderstanding that needs careful correction. For example, a patient seeking dermal filler for profound skin laxity may need an explanation of why filler is not the best answer, alongside discussion of non-intervention, skin-quality strategies or referral for a surgical opinion.
Clinical assessment must sit alongside this conversation. Relevant medical history, allergies, medicines, previous procedures, prior complications and mental health history can all affect suitability. A history of repeated dissatisfaction after technically appropriate treatments requires particular attention. It does not automatically preclude care, but it should prompt a slower, more searching consultation and, where appropriate, a decision not to treat.
Explain the treatment in language the patient can use
Clinical accuracy need not mean clinical jargon. Patients should understand what is being proposed, where it will be placed or applied, what it is designed to do and what it cannot do. It is useful to explain the difference between temporary improvement and permanent change, between skin rejuvenation and structural correction, and between a subtle result and a transformation.
Risks should be discussed in proportion to their seriousness and likelihood. Common effects such as swelling, bruising and temporary discomfort should be covered, but rare and serious complications must not be buried in dense text. With injectables, this may include vascular compromise, skin injury and visual complications where relevant to the procedure. With energy-based devices, pigmentary change, burns and scarring may need discussion. The precise content depends on the treatment, patient characteristics and technique.
The patient should also hear about practical consequences: downtime, cost, the possibility of staged treatment, maintenance requirements and what happens if they do not like the result. In regenerative and biostimulatory treatments, explain that outcomes can be gradual and variable. Biological response cannot be guaranteed, and a responsible clinician should say so plainly.
Discuss alternatives, including doing nothing
Consent is weakened when the proposed treatment is presented as the only sensible route. Patients should know about clinically reasonable alternatives, which may include another modality, deferring treatment, referral to a colleague or choosing no treatment at all.
This discussion does not need to become a catalogue of every intervention available. It should be relevant to the patient's concern and informed by the clinician's assessment. The central question is whether the patient understands the material options that could reasonably influence their decision.
For some patients, the most appropriate recommendation is to pause. A cooling-off period can be particularly valuable for first-time patients, high-cost plans, invasive procedures, major changes to appearance or decisions made during emotional distress. A patient who is certain after time to reflect is more likely to be making an autonomous decision than one responding to urgency or sales pressure.
Check understanding rather than assuming it
A signature confirms little on its own. Patients may sign without reading, may feel embarrassed to ask questions or may believe that a complication is too unlikely to matter. The clinician should actively check understanding before treatment.
A simple teach-back approach is effective: ask the patient to describe, in their own words, what treatment is planned, the main risks, the expected recovery and what they would do if they became concerned afterwards. This is not an examination. It is a respectful way to identify gaps in communication.
Where there are language barriers, hearing difficulties, cognitive concerns or limited health literacy, the process must be adapted. Provide information in an accessible format and use an appropriate independent interpreter where necessary. Do not rely on a family member to translate sensitive medical information, particularly where the patient may feel unable to disagree with them.
Capacity is decision-specific and can change with circumstance. If a clinician is not satisfied that a patient can understand, retain, weigh and communicate the relevant information, treatment should not proceed. Equally, a capacitous patient's decision is not invalid merely because a clinician would make another choice. The professional duty is to ensure that the decision is informed, voluntary and clinically appropriate.
Document a decision, not merely a form
Good records protect patients first and clinics second. They demonstrate that the consultation was individualised, that risks and alternatives were addressed, and that the treatment plan was based on an assessment rather than a predetermined sale.
The record should capture the patient's stated concerns and goals, relevant history, examination findings, recommended treatment and any advice against treatment. It should note material risks discussed, alternatives considered, questions asked, cooling-off advice where given and the patient's decision. Procedure-specific consent documentation remains useful, but it should support, not replace, the consultation note.
Photography requires its own clear consent. Patients should know why images are being taken, how they will be stored, who can access them and whether any separate permission is sought for education, publication or marketing. Consent for clinical records is not consent for promotional use. Keeping these decisions separate is both ethical and prudent.
Build consent into clinic culture
The most reliable way to improve consent in aesthetic clinics is to make it a shared standard, not the responsibility of one practitioner on one busy day. Reception and patient co-ordinators should avoid language that implies guarantees, urgency or entitlement to treatment. Marketing should not promise outcomes that the consultation cannot ethically support.
Clinical teams benefit from regular review of consent documents, adverse events, complaints and near misses. If patients repeatedly report surprise about downtime, pain, cost or the need for maintenance, the information process needs revision. Consent materials should evolve as techniques, products, evidence and safety guidance change.
Professor Patrick Treacy's long-standing emphasis on complications management and patient safety reflects a central truth of modern aesthetic practice: expertise is shown not only in selecting and delivering treatment, but also in knowing when to slow down, explain more carefully or decline to proceed.
A well-consented patient is not simply one who has accepted risk. They are a patient who understands the proposed care, feels free to choose and can trust that their long-term wellbeing has been placed above the pressure to perform a procedure.